Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species.

R Palacios Centro Internacional de Entrenamiento e Investigaciones Médicas, Cali, Colombia. clinica@cideim.org.co

Search for other papers by R Palacios in
Current site
Google Scholar
PubMed Close
,
L E Osorio Centro Internacional de Entrenamiento e Investigaciones Médicas, Cali, Colombia. clinica@cideim.org.co

Search for other papers by L E Osorio in
Current site
Google Scholar
PubMed Close
,
L F Grajalew Centro Internacional de Entrenamiento e Investigaciones Médicas, Cali, Colombia. clinica@cideim.org.co

Search for other papers by L F Grajalew in
Current site
Google Scholar
PubMed Close
, and
M T Ochoa Centro Internacional de Entrenamiento e Investigaciones Médicas, Cali, Colombia. clinica@cideim.org.co

Search for other papers by M T Ochoa in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.4269/ajtmh.2001.64.187
Volume/Issue:
Volume 64: Issue 3
Page(s):
187–193
Restricted access
Get Permissions

Clinical response to supervised treatment of Colombian patients with cutaneous leishmaniasis was evaluated in a randomized controlled trial comparing 10 days versus 20 days of treatment with meglumine antimonate (20 mg Sb/kg/day). Masked examiners evaluated clinical response defined as 100% re-epithelialization of all lesions at 13 weeks and no relapses during 52 weeks of follow-up. The efficacy of meglumine antimonate for 10 days' treatment was 61% (28 of 46) compared to 67% (24 of 36) for 20 days. There was a significantly lower clinical response for children < 5 years in both 10-day (11%) and 20-day (25%) groups compared to patients aged 5-14 years (67% and 75%, respectively) and 15 years or more (81% and 83%, respectively). Overall efficacy of treatment schedules was comparable, but lower than expected, mainly because of low efficacy in children. Pathogenicity of infection and pharmacokinetics may affect the treatment response in children. New therapeutic alternatives should be evaluated in trials that include children and women.

Published Online:
Mar 2001
Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637
Past two years Past Year Past 30 Days
Abstract Views 35 35 9
Full Text Views 541 212 0
PDF Downloads 180 53 0
 
Membership Banner
 
 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save